A better COVID treatment for the immunocompromised?A combination of two antiviral compounds may be a promising alternative to Paxlovid when treating COVID-19 in immunocompromised patients, Yale researchers find.
Five Things to Know About… the Three-Minute Thesis Competition Alison Cole ’99 named executive director of Yale Alumni Association VideoPlaying together: At the Yale School of Music, García-León builds community Perinatal substance use may shape how strongly mothers feel toward infants